These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33881645)

  • 1. Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone.
    Standeven LR; Olson E; Leistikow N; Payne JL; Osborne LM; Hantsoo L
    Curr Psychiatry Rep; 2021 Apr; 23(6):36. PubMed ID: 33881645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle.
    Hantsoo L; Epperson CN
    Neurobiol Stress; 2020 May; 12():100213. PubMed ID: 32435664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopregnanolone as a mediator of affective switching in reproductive mood disorders.
    Schiller CE; Schmidt PJ; Rubinow DR
    Psychopharmacology (Berl); 2014 Sep; 231(17):3557-67. PubMed ID: 24846476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
    Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
    Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
    Elife; 2023 Aug; 12():. PubMed ID: 37534878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome.
    Jedel E; Gustafson D; Waern M; Sverrisdottir YB; Landén M; Janson PO; Labrie F; Ohlsson C; Stener-Victorin E
    Psychoneuroendocrinology; 2011 Nov; 36(10):1470-9. PubMed ID: 21549510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric comorbidities and adverse childhood experiences in women with self-reported polycystic ovary syndrome: An Australian population-based study.
    Tay CT; Teede HJ; Loxton D; Kulkarni J; Joham AE
    Psychoneuroendocrinology; 2020 Jun; 116():104678. PubMed ID: 32361187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
    Cooney LG; Lee I; Sammel MD; Dokras A
    Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Brutocao C; Zaiem F; Alsawas M; Morrow AS; Murad MH; Javed A
    Endocrine; 2018 Nov; 62(2):318-325. PubMed ID: 30066285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopregnanolone and mood disorders.
    Bäckström T; Bixo M; Johansson M; Nyberg S; Ossewaarde L; Ragagnin G; Savic I; Strömberg J; Timby E; van Broekhoven F; van Wingen G
    Prog Neurobiol; 2014 Feb; 113():88-94. PubMed ID: 23978486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolites of progesterone in pregnancy: Associations with perinatal anxiety.
    Etyemez S; Miller KN; Voegtline KM; Özdemir İ; Standeven LR; Santovito LS; Pinna G; Payne JL; Osborne LM
    Psychoneuroendocrinology; 2023 Oct; 156():106327. PubMed ID: 37423029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women with polycystic ovary syndrome have elevated serum concentrations of and altered GABA(A) receptor sensitivity to allopregnanolone.
    Hedström H; Bäckström T; Bixo M; Nyberg S; Wang M; Gideonsson I; Turkmen S
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):643-50. PubMed ID: 25929428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort.
    Cesta CE; Månsson M; Palm C; Lichtenstein P; Iliadou AN; Landén M
    Psychoneuroendocrinology; 2016 Nov; 73():196-203. PubMed ID: 27513883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychiatric disorders in women with polycystic ovary syndrome.
    Rodriguez-Paris D; Remlinger-Molenda A; Kurzawa R; Głowińska A; Spaczyński R; Rybakowski F; Pawełczyk L; Banaszewska B
    Psychiatr Pol; 2019 Aug; 53(4):955-966. PubMed ID: 31760419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroactive Steroids and Affective Symptoms in Women Across the Weight Spectrum.
    Dichtel LE; Lawson EA; Schorr M; Meenaghan E; Paskal ML; Eddy KT; Pinna G; Nelson M; Rasmusson AM; Klibanski A; Miller KK
    Neuropsychopharmacology; 2018 May; 43(6):1436-1444. PubMed ID: 29090684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of emotional problems and mood disorders in women with polycystic ovary syndrome.
    Głowińska A; Zielona-Jenek M; Pawelczyk A; Banaszewska BE
    Ginekol Pol; 2016; 87(6):405-10. PubMed ID: 27418215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emotion-induced brain activation across the menstrual cycle in individuals with premenstrual dysphoric disorder and associations to serum levels of progesterone-derived neurosteroids.
    Stiernman L; Dubol M; Comasco E; Sundström-Poromaa I; Boraxbekk CJ; Johansson M; Bixo M
    Transl Psychiatry; 2023 Apr; 13(1):124. PubMed ID: 37055419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years.
    Fernandez RC; Moore VM; Rumbold AR; Whitrow MJ; Avery JC; Davies MJ
    Hum Reprod; 2021 Jul; 36(8):2275-2284. PubMed ID: 33963388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome and postpartum depression: A systematic review and meta-analysis of observational studies.
    Schoretsanitis G; Gastaldon C; Kalaitzopoulos DR; Ochsenbein-Koelble N; Barbui C; Seifritz E
    J Affect Disord; 2022 Feb; 299():463-469. PubMed ID: 34952106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.